Committee reviews H.577 to join ArrayRx discount‑card collaboration; treasurer seeks $50,000 start‑up appropriation

The House Ways & Means Committee on Wednesday heard detailed testimony on H.577, a bill to create the Vermont Prescription Drug Discount Card Program and join a multi‑state ArrayRx collaboration intended to reduce out‑of‑pocket prescription costs for Vermonters.

Treasurer’s office representatives told the committee the ArrayRx model is run operationally by staff in other states and offers a free discount card that can produce deep pharmacy discounts at the point of sale. "If we got the same take up that Connecticut has received ... we would see ... $18,000,000 a year" in savings, a Treasurer's office presenter said. The sponsor’s proposal asks the Legislature to appropriate $50,000 as a one‑time start‑up cost for outreach and marketing and to permit the Treasurer to require "reasonable fees" to defray program costs.

The bill would establish the program in a new subchapter of 18 V.S.A., chapter 91, assign administration to the Office of the State Treasurer, authorize fee collection based on actual costs, require insurers and pharmacy benefit managers to provide forms so discount‑card out‑of‑pocket payments can be credited toward deductibles and out‑of‑pocket maximums, and require an annual report beginning Jan. 15, 2028, covering participation, savings and the program fund balance.

Committee members questioned several operational and legal details. Members asked whether the discount arrangement covers national chains and specialty mail‑order pharmacies; the presenter said ArrayRx contracts include both brick‑and‑mortar and online pharmacies and that coverage has included national chains in other states. On privacy, a committee member asked whether federal agencies could access enrollment or usage data; a Treasurer's office witness said Oregon will maintain anonymized program data and that the collaborative’s model does not sell consumer data: "this data is not sold or provided to any one outside of the state or outside the state collaborative," the presenter said.

Members also pressed the Treasurer’s office and Office of Legislative Council on fee authority and the program’s finance structure. H.577 authorizes the Treasurer to require reasonable participant fees to defray costs, but the bill does not specify a dollar amount or exactly who would pay such a fee. The committee sought clarification about whether a fee would be charged to card users, pharmacies, or paid through state aggregation, and whether Vermont can be exempted from or withdraw from the collaborative without liability; witnesses said contractual terms will be reviewed by the Treasurer’s legal team and that withdrawal provisions are typically negotiated in contracts but aren’t specified in the draft statute.

The Joint Fiscal Office described the bill’s budget effects as limited in the near term: section 5 would appropriate $50,000 from the General Fund for development and marketing, and the authorization for fees and a special fund would permit the Treasurer to retain and use program revenue. The fiscal analyst noted pros and cons of creating another special fund and said existing state accounting offices could track revenues without a special fund, depending on policy decisions.

Committee members requested the Treasurer’s office return with more detail on anticipated fee amounts and collection mechanisms and debated narrowing fee authority in statutory language. No vote was taken; the chair said the committee expects to vote on H.577 tomorrow. The meeting recessed for a 10‑minute break and was scheduled to resume at 10:35 a.m. to address property‑tax classification items.